© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.
Cameron Santoro is an associate editor for The Center for Biosimilars®, The American Journal of Managed Care® (AJMC), and AJMC.com.
July 25, 2025
Video
Here are the top 5 biosimilar articles for the week of July 21, 2025.
July 18, 2025
Video
Here are the top 5 biosimilar articles for the week of July 14, 2025.
July 14, 2025
Article
Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, supports biosimilars for cost savings but foresees challenges adopting an intravenous daratumumab biosimilar, preferring the more convenient subcutaneous option.
July 11, 2025
Video
Here are the top 5 biosimilar articles for the week of July 7, 2025.
July 04, 2025
Video
Here are the top 5 biosimilar articles for the week of June 30, 2025.
July 03, 2025
Article
Biosimilar SB12 demonstrated comparable efficacy and safety for paroxysmal nocturnal hemoglobinuria (PNH) to its reference drug, showing similar outcomes across diverse patient groups.
June 29, 2025
Video
Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, explain that widespread biosimilar adoption requires addressing patient and provider education gaps through pharmacists and rectifying perverse financial incentives within health care contract structures.
June 27, 2025
Video
Here are the top 5 biosimilar articles for the week of June 23, 2025.
June 20, 2025
Video
Here are the top 5 biosimilar articles for the week of June 16, 2025.
June 19, 2025
Article
Tocilizumab biosimilar CT-P47, administered via autoinjector, offers comparable efficacy and a consistent safety profile to reference tocilizumab in patients with rheumatoid arthritis.